Cargando…

309. Should Primary Care Practitioners Follow Hepatitis C Exposed Infants?

BACKGROUND: Hepatits C virus (HCV) infection in pregnancy is estimated between 1–4% and risk of vertical transmission ~5%. While the benefits of HCV testing for perinatally exposed infants under a year is debatable, a strategy for follow-up (F/U) is important. We instituted interventions to improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Merjaneh, Nawal, Smotherman, Carmen, Maraqa, Nizar, Mirza, Ayesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809677/
http://dx.doi.org/10.1093/ofid/ofz360.382
_version_ 1783462050837561344
author Merjaneh, Nawal
Smotherman, Carmen
Maraqa, Nizar
Mirza, Ayesha
author_facet Merjaneh, Nawal
Smotherman, Carmen
Maraqa, Nizar
Mirza, Ayesha
author_sort Merjaneh, Nawal
collection PubMed
description BACKGROUND: Hepatits C virus (HCV) infection in pregnancy is estimated between 1–4% and risk of vertical transmission ~5%. While the benefits of HCV testing for perinatally exposed infants under a year is debatable, a strategy for follow-up (F/U) is important. We instituted interventions to improve the F/U rate for HCV exposed infants in December 2012. Pediatric infectious diseases (PID) service was consulted in the newborn period to establish care. Perinatal HCV exposure was added to the infant’s electronic record. Educational brochures were given to guardians at discharge. We aimed to assess the efficacy of the interventions in improving the F/U rate. METHODS: A retrospective chart review of 227 HCV exposed infants born between January 2013 and December 2016 was done after obtaining IRB. Infant charts were reviewed for maternal age, race, insurance, HCV risk factors, HIV and Hep B co-infection, third trimester HCV PCR, delivery type, gestational age, birth weight and infant custody. Based on 2002 NIH guidelines: first visit at 6–8 weeks, second at 6–8 months, final visit ≥18 months of age. Maternal HCV infection is positive HCV antibody (Ab) during pregnancy, medical care defined as at least one infant PID clinic visit, and appropriate F/U as an 18-month visit for HCV (Ab) check. Univariate analysis is used for demographics, descriptive summaries were recorded as frequencies and percentages. RESULTS: 214 infants included in analysis (1 deceased and 12 adopted and left area). Baseline characteristics of those who had medical care vs. not were similar except for infant custody and HIV co-infection 94/214 (44%) had medical care. Of those, 32/94(34%) had appropriate F/U while 62/94(66%) did not 31/214 infants were followed by primary care practitioners (PCPs) at our institution. Of those 24/31(77.5%) were either tested inappropriately or lost to F/U HIV co- infection and custody by a relative (not mom) increase the likelihood of F/U (P 0.003 and 0.002, respectively) 5 infants contracted HCV infection. One infant who lost to F/U was diagnosed incidentally in the ER. CONCLUSION: Appropriate F/U for HCV exposed infants poses challenges despite established systems of care. Because current guidelines recommend antibody testing at 18 months, educating PCPs who are more likely to establish regular F/U is important for appropriate testing. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809677
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68096772019-10-28 309. Should Primary Care Practitioners Follow Hepatitis C Exposed Infants? Merjaneh, Nawal Smotherman, Carmen Maraqa, Nizar Mirza, Ayesha Open Forum Infect Dis Abstracts BACKGROUND: Hepatits C virus (HCV) infection in pregnancy is estimated between 1–4% and risk of vertical transmission ~5%. While the benefits of HCV testing for perinatally exposed infants under a year is debatable, a strategy for follow-up (F/U) is important. We instituted interventions to improve the F/U rate for HCV exposed infants in December 2012. Pediatric infectious diseases (PID) service was consulted in the newborn period to establish care. Perinatal HCV exposure was added to the infant’s electronic record. Educational brochures were given to guardians at discharge. We aimed to assess the efficacy of the interventions in improving the F/U rate. METHODS: A retrospective chart review of 227 HCV exposed infants born between January 2013 and December 2016 was done after obtaining IRB. Infant charts were reviewed for maternal age, race, insurance, HCV risk factors, HIV and Hep B co-infection, third trimester HCV PCR, delivery type, gestational age, birth weight and infant custody. Based on 2002 NIH guidelines: first visit at 6–8 weeks, second at 6–8 months, final visit ≥18 months of age. Maternal HCV infection is positive HCV antibody (Ab) during pregnancy, medical care defined as at least one infant PID clinic visit, and appropriate F/U as an 18-month visit for HCV (Ab) check. Univariate analysis is used for demographics, descriptive summaries were recorded as frequencies and percentages. RESULTS: 214 infants included in analysis (1 deceased and 12 adopted and left area). Baseline characteristics of those who had medical care vs. not were similar except for infant custody and HIV co-infection 94/214 (44%) had medical care. Of those, 32/94(34%) had appropriate F/U while 62/94(66%) did not 31/214 infants were followed by primary care practitioners (PCPs) at our institution. Of those 24/31(77.5%) were either tested inappropriately or lost to F/U HIV co- infection and custody by a relative (not mom) increase the likelihood of F/U (P 0.003 and 0.002, respectively) 5 infants contracted HCV infection. One infant who lost to F/U was diagnosed incidentally in the ER. CONCLUSION: Appropriate F/U for HCV exposed infants poses challenges despite established systems of care. Because current guidelines recommend antibody testing at 18 months, educating PCPs who are more likely to establish regular F/U is important for appropriate testing. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809677/ http://dx.doi.org/10.1093/ofid/ofz360.382 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Merjaneh, Nawal
Smotherman, Carmen
Maraqa, Nizar
Mirza, Ayesha
309. Should Primary Care Practitioners Follow Hepatitis C Exposed Infants?
title 309. Should Primary Care Practitioners Follow Hepatitis C Exposed Infants?
title_full 309. Should Primary Care Practitioners Follow Hepatitis C Exposed Infants?
title_fullStr 309. Should Primary Care Practitioners Follow Hepatitis C Exposed Infants?
title_full_unstemmed 309. Should Primary Care Practitioners Follow Hepatitis C Exposed Infants?
title_short 309. Should Primary Care Practitioners Follow Hepatitis C Exposed Infants?
title_sort 309. should primary care practitioners follow hepatitis c exposed infants?
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809677/
http://dx.doi.org/10.1093/ofid/ofz360.382
work_keys_str_mv AT merjanehnawal 309shouldprimarycarepractitionersfollowhepatitiscexposedinfants
AT smothermancarmen 309shouldprimarycarepractitionersfollowhepatitiscexposedinfants
AT maraqanizar 309shouldprimarycarepractitionersfollowhepatitiscexposedinfants
AT mirzaayesha 309shouldprimarycarepractitionersfollowhepatitiscexposedinfants